| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
*
Laboratory of Immunophysiology, Department of Animal Sciences, and
College of Medicine, Department of Pathology, University of Illinois, Urbana, IL 61801; and
Institut National de la Recherche Agronomique (INRA)-Institut National de la Santé et de la Recherche Médicale (INSERM) U394, Institut François Magendie, Bordeaux, France
Phosphatidylinositol 3'-kinase (PI 3-kinase) catalyzes the formation of 3' phosphoinositides and has been implicated in an intracellular signaling pathway that inhibits apoptosis in both neuronal and hemopoietic cells. Here, we investigated two potential downstream mediators of PI 3-kinase, the serine/threonine p70 S6-kinase (S6-kinase) and the antiapoptotic protein B cell lymphoma-2 (Bcl-2). Stimulation of factor-dependent cell progenitor (FDCP) cells with either IL-4 or insulin-like growth factor (IGF)-I induced a 10-fold increase in the activity of both PI 3-kinase and S6-kinase. Rapamycin blocked 90% of the S6-kinase activity but did not affect PI 3-kinase, whereas wortmannin and LY294002 inhibited the activity of both S6-kinase and PI 3-kinase. However, wortmannin and LY294002, but not rapamycin, blocked the ability of IL-4 and IGF-I to promote cell survival. We next established that IL-3, IL-4, and IGF-I increase expression of Bcl-2 by >3-fold. Pretreatment with inhibitors of PI 3-kinase, but not rapamycin, abrogated expression of Bcl-2 caused by IL-4 and IGF-I, but not by IL-3. None of the cytokines affected expression of the proapoptotic protein Bax, suggesting that all three cytokines were specific for Bcl-2. These data establish that inhibition of PI 3-kinase, but not S6-kinase, blocks the ability of IL-4 and IGF-I to increase expression of Bcl-2 and protect promyeloid cells from apoptosis. The requirement for PI 3-kinase to maintain Bcl-2 expression depends upon the ligand that activates the cell survival pathway.
This article has been cited by other articles:
|
|
 |
|
  H. V. Jain, J. E. Nor, and T. L. Jackson Quantification of endothelial cell-targeted anti-Bcl-2 therapy and its suppression of tumor growth and vascularization Mol. Cancer Ther., October 1, 2009; 8(10): 2926 - 2936. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Riou, A. R Dumont, B. Yassine-Diab, E. K Haddad, and R.-P. Sekaly IL-4 influences the differentiation and the susceptibility to activation-induced cell death of human naive CD8+ T cells Int. Immunol., June 1, 2006; 18(6): 827 - 835. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Hartman, J. C. O'Connor, J. P. Godbout, K. D. Minor, V. R. Mazzocco, and G. G. Freund Insulin Receptor Substrate-2-dependent Interleukin-4 Signaling in Macrophages Is Impaired in Two Models of Type 2 Diabetes Mellitus J. Biol. Chem., July 2, 2004; 279(27): 28045 - 28050. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. H. Shen, S. T. Jackson, S. R. Broussard, R. H. McCusker, K. Strle, G. G. Freund, R. W. Johnson, R. Dantzer, and K. W. Kelley IL-1{beta} Suppresses Prolonged Akt Activation and Expression of E2F-1 and Cyclin A in Breast Cancer Cells J. Immunol., June 15, 2004; 172(12): 7272 - 7281. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Kelly-Welch, H. Y. Wang, L.-M. Wang, J. H. Pierce, G. Jay, F. Finkelman, and A. D. Keegan Transgenic Expression of Insulin Receptor Substrate 2 in Murine B Cells Alters the Cell Density-Dependence of IgE Production In Vitro and Enhances IgE Production In Vivo J. Immunol., March 1, 2004; 172(5): 2803 - 2810. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-H. Tseng, K. Ueki, K. M. Kriauciunas, and C. R. Kahn Differential Roles of Insulin Receptor Substrates in the Anti-apoptotic Function of Insulin-like Growth Factor-1 and Insulin J. Biol. Chem., August 23, 2002; 277(35): 31601 - 31611. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.-H. Shen, J.-H. Zhou, S. R. Broussard, G. G. Freund, R. Dantzer, and K. W. Kelley Proinflammatory Cytokines Block Growth of Breast Cancer Cells by Impairing Signals from a Growth Factor Receptor Cancer Res., August 15, 2002; 62(16): 4746 - 4756. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. R. Wilkins, K. Ohneda, T. O. Keku, A. J. D'Ercole, C. R. Fuller, K. L. Williams, and P. K. Lund Reduction of spontaneous and irradiation-induced apoptosis in small intestine of IGF-I transgenic mice Am J Physiol Gastrointest Liver Physiol, August 1, 2002; 283(2): G457 - G464. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. E. Pardo, A. Arcaro, G. Salerno, S. Raguz, J. Downward, and M. J. Seckl Fibroblast Growth Factor-2 Induces Translational Regulation of Bcl-XL and Bcl-2 via a MEK-dependent Pathway. CORRELATION WITH RESISTANCE TO ETOPOSIDE-INDUCED APOPTOSIS J. Biol. Chem., March 29, 2002; 277(14): 12040 - 12046. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. T. Iida, H. Suzuki, H. Sone, H. Shimano, H. Toyoshima, S. Yatoh, T. Asano, Y. Okuda, and N. Yamada Insulin Inhibits Apoptosis of Macrophage Cell Line, THP-1 Cells, via Phosphatidylinositol-3-Kinase-Dependent Pathway Arterioscler Thromb Vasc Biol, March 1, 2002; 22(3): 380 - 386. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. French, S. R. Broussard, W. A. Meier, C. Minshall, S. Arkins, J. F. Zachary, R. Dantzer, and K. W. Kelley Age-Associated Loss of Bone Marrow Hematopoietic Cells Is Reversed by GH and Accompanies Thymic Reconstitution Endocrinology, February 1, 2002; 143(2): 690 - 699. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Goyal, Y. Wang, M. M. Graham, A. I. Doseff, N. Y. Bhatt, and C. B. Marsh Monocyte Survival Factors Induce Akt Activation and Suppress Caspase-3 Am. J. Respir. Cell Mol. Biol., February 1, 2002; 26(2): 224 - 230. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-H. Zhou, S. R. Broussard, K. Strle, G. G. Freund, R. W. Johnson, R. Dantzer, and K. W. Kelley IL-10 Inhibits Apoptosis of Promyeloid Cells by Activating Insulin Receptor Substrate-2 and Phosphatidylinositol 3'-Kinase J. Immunol., October 15, 2001; 167(8): 4436 - 4442. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Beery, M. Haimsohn, N. Wertheim, R. Hemi, U. Nir, A. Karasik, H. Kanety, and A. Geier Activation of the Insulin-Like Growth Factor 1 Signaling Pathway by the Antiapoptotic Agents Aurintricarboxylic Acid and Evans Blue Endocrinology, July 1, 2001; 142(7): 3098 - 3107. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Smith, A. E. Schaffner, J. K. Hofmeister, M. Hartman, G. Wei, D. Forsthoefel, D. A. Hume, and M. C. Ostrowski ets-2 Is a Target for an Akt (Protein Kinase B)/Jun N-Terminal Kinase Signaling Pathway in Macrophages of motheaten-viable Mutant Mice Mol. Cell. Biol., November 1, 2000; 20(21): 8026 - 8034. [Abstract] [Full Text]
|
|
|
|
|
|
W. Li, T. Hyun, M. Heller, A. Yam, L. Flechner, J. H. Pierce, and S. Rudikoff Activation of Insulin-like Growth Factor I Receptor Signaling Pathway Is Critical for Mouse Plasma Cell Tumor Growth Cancer Res., July 1, 2000; 60(14): 3909 - 3915. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. Dorshkind and N. D. Horseman The Roles of Prolactin, Growth Hormone, Insulin-Like Growth Factor-I, and Thyroid Hormones in Lymphocyte Development and Function: Insights from Genetic Models of Hormone and Hormone Receptor Deficiency Endocr. Rev., June 1, 2000; 21(3): 292 - 312. [Abstract] [Full Text]
|
|
|
|
|
|
F. Ahmad, L.-N. Cong, L. Stenson Holst, L.-M. Wang, T. Rahn Landstrom, J. H. Pierce, M. J. Quon, E. Degerman, and V. C. Manganiello Cyclic Nucleotide Phosphodiesterase 3B Is a Downstream Target of Protein Kinase B and May Be Involved in Regulation of Effects of Protein Kinase B on Thymidine Incorporation in FDCP2 Cells J. Immunol., May 1, 2000; 164(9): 4678 - 4688. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. D. Venters, Q. Tang, Q. Liu, R. W. VanHoy, R. Dantzer, and K. W. Kelley A new mechanism of neurodegeneration: A proinflammatory cytokine inhibits receptor signaling by a survival peptide PNAS, August 17, 1999; 96(17): 9879 - 9884. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
